Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Direvo (Novel feed enzyme)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Novel feed enzyme. The enzyme is a tailor-made feed enzyme and is an optimized and improved version of mannanase enzyme.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Commercial Products
Acquirer
Primary Office
  • Nattermannallee 1
  • 50829 Köln
  • Germany

Direvo (Novel feed enzyme) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Direvo (Novel feed enzyme)‘s full profile, request access.

Request full access to PitchBook

Direvo (Novel feed enzyme) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Direvo (Novel feed enzyme)‘s full profile, request access.

Request full access to PitchBook